Aimmune Therapeutics, Inc. Operating Income 2015-2020 | AIMT
Aimmune Therapeutics, Inc. operating income from 2015 to 2020. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Aimmune Therapeutics, Inc. Annual Operating Income (Millions of US $) |
|
|---|---|
| 2019 | $-250 |
| 2018 | $-215 |
| 2017 | $-133 |
| 2016 | $-82 |
| 2015 | $-36 |
| 2014 | $-11 |
| 2013 | $-5 |
| Aimmune Therapeutics, Inc. Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2020-06-30 | $-66 |
| 2020-03-31 | $-85 |
| 2019-12-31 | $-67 |
| 2019-09-30 | $-65 |
| 2019-06-30 | $-63 |
| 2019-03-31 | $-55 |
| 2018-12-31 | $-58 |
| 2018-09-30 | $-53 |
| 2018-06-30 | $-54 |
| 2018-03-31 | $-50 |
| 2017-12-31 | $-42 |
| 2017-09-30 | $-32 |
| 2017-06-30 | $-33 |
| 2017-03-31 | $-26 |
| 2016-12-31 | $-25 |
| 2016-09-30 | $-22 |
| 2016-06-30 | $-18 |
| 2016-03-31 | $-16 |
| 2015-12-31 | $-16 |
| 2015-09-30 | $-9 |
| 2015-06-30 | $-7 |
| 2015-03-31 | $-3 |
| 2014-09-30 | $-3 |
| 2014-06-30 | $-3 |
